Jane Street’s InflaRx IFRX Stock Holding History

Jane Street’s Portfolio IFRX Stock Details IFRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,500	Closed	-$13.6K	–	12215
2025 Q4	$13.6K	Buy	+13,500	New	+$16.8K	﹤0.01%	10791

Other funds holding IFRX

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

T3 Companies New York $76.8M AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Jane Street's IFRX Position: Q1 2026 in Review

Jane Street sold out of InflaRx (IFRX) in Q1 2026, closing a stake of 181,716 shares — an estimated $172K sold.

Jane Street first reported a position in IFRX in Q3 2018 and held it in 5 quarters. The position peaked at $278K in Q3 2018. 35 funds tracked by Wall St. Rank hold IFRX as of Q1 2026.

Jane Street reported no remaining InflaRx position as of Q1 2026 after selling out during the quarter.
Jane Street sold 181,716 InflaRx shares in Q1 2026, an estimated $172K.
Jane Street first reported a position in InflaRx in Q3 2018 and held it in 5 quarters.
Jane Street's InflaRx position peaked at $278K in Q3 2018.
35 funds tracked by Wall St. Rank held InflaRx as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.